PD-1 antagonists and methods of use thereof

Details for Australian Patent Application No. 2009288289 (hide)

Owner Amplimmune, Inc.

Inventors Langermann, Solomon; Liu, Linda

Agent Davies Collison Cave

Pub. Number AU-A-2009288289

PCT Pub. Number WO2010/027828

Priority 61/091,694 25.08.08 US; 61/142,548 05.01.09 US; 61/165,652 01.04.09 US; 61/091,502 25.08.08 US; 61/091,709 25.08.08 US; 61/091,705 25.08.08 US

Filing date 25 August 2009

Wipo publication date 11 March 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/027828 Priority application(s): WO2010/027828

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009288317-Apparatus for opening and closing molds in a glassware forming machine

2009288277-Pharmaceutical composition having relatively low ionic strength